$2.99
-0.05-1.64%
Last update: Nov 3, 4:02 PM
Neuphoria Therapeutics Inc
NEUPNASDAQ
Neuphoria Therapeutics (NEUP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.56 | $-0.56 | $-1.01 |
| Actual | $-0.95 | $-0.09 | $-0.77 | $-4.41 |
| Surprise | -69.6% | +83.9% | -37.5% | -336.6% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $1.2M | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q1 '27E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-0.42 |
| Revenue | |
| Consensus | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Sep 18, 2026 | $-0.95 | $-0.56 | -69.6 % |
| Q3 | May 15, 2026 | $-0.09 | $-0.56 | 83.9 % |
| Q2 | Feb 17, 2026 | $-0.77 | $-0.56 | -37.5 % |
| Q1 | Nov 14, 2025 | $-4.41 | $-1.01 | -336.6 % |
